[Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+

Y Furukawa1, K Tanaka, T Hasuike

  • 1Department of Laboratory Medicine, Osaka City University Medical School.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 1, 1991
PubMed

Insights

This study details a rare case of T-cell large granular lymphocyte (T-LGL) leukemia presenting with thrombocytopenia. The findings suggest a potential shared origin for T-LGL and natural killer (NK) cells.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder.
  • Distinguishing between T-cell LGL (T-LGL) and natural killer (NK) cell lymphocytosis can be challenging.
  • This case explores the immunophenotypic characteristics and clinical course of a patient with suspected T-LGL leukemia.

Observation:

  • A 33-year-old male presented with thrombocytopenia and splenomegaly.
  • Peripheral blood flow cytometry revealed abnormal lymphocytes expressing CD2, CD3, CD11, CD16, and CD56 (T-LGL).
  • Lymph node lymphocytes expressed CD2, CD16, CD38, and CD56, but lacked CD3 (NK cells).

Findings:

  • Splenectomy specimen showed infiltration by pleomorphic lymphocytes, consistent with chronic lymphocytic leukemia.
  • Post-splenectomy, platelet counts normalized, but lymphocytosis persisted.
  • The patient later required chemotherapy for recurrent thrombocytopenia and hepatomegaly, ultimately succumbing to sepsis-induced disseminated intravascular coagulation.

Implications:

  • The distinct yet overlapping immunophenotypes of lymphocytes from peripheral blood and lymph nodes suggest a possible common progenitor for T-LGL and NK cells.
  • This case highlights the complex clinical presentation and potential diagnostic challenges in LGL lymphoproliferative disorders.
  • Further research into the differentiation pathways of LGL and NK cells is warranted.